NCT02324387 2026-03-09
Tc99m Sestamibi Molecular Breast Imaging
M.D. Anderson Cancer Center
Phase NA Active not recruiting
Clinical Trials
9 trialsNCT05042687 2025-10-27
Comparative Performance of Molecular Breast Imaging (MBI) to Magnetic Resonance Imaging (MRI) of the Breast in Identifying and Excluding Breast Carcinoma in Women at High Risk for Breast Cancer
M.D. Anderson Cancer Center
Phase NA Recruiting
NCT02744053 2025-10-20
DCE-MRI and MBI in Assessing Tumor Response to Chemotherapy in Patients With Triple Negative Breast Cancer
M.D. Anderson Cancer Center
Phase EARLY_PHASE1 Active not recruiting
NCT06058650 2025-09-30
Molecular Breast Imaging Guidance for Breast Biopsy for Patients With Breast Abnormalities
Mayo Clinic
Phase NA Recruiting
NCT03065218 2022-07-26
99mTc Sestamibi Scans In Thyroglobulin Positive Scan Negative Differentiated Thyroid Cancer (DTC) Patients
Medstar Health Research Institute
Phase 4 Terminated
NCT01925170 2014-08-19
Low Dose Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts
Mayo Clinic
Phase NA Completed
NCT00620373 2014-08-01
Molecular Breast Imaging as a Screening Tool for Women With Dense Breasts
Mayo Clinic
Phase NA Completed
NCT00069160 2012-10-12
Tariquidar and Docetaxel to Treat Patients With Lung, Ovarian, Renal and Cervical Cancer
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT00972205 2012-07-19
Paclitaxel and CBT-1(Registered Trademark) to Treat Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase NA Completed